← Retour à la une
États-Unis · Plateformes & données · MarketBeat

FY2029 EPS Forecast for Kura Oncology Decreased by Analyst

Publié par MarketBeat · États-Unis il y a 18 min
Image from MarketBeat Media, LLC.
Image from MarketBeat Media, LLC. · MarketBeat

Résumé détaillé

Kura Oncology, Inc. (NASDAQ:KURA - Free Report) - Equities research analysts at Brookline Capital Markets dropped their FY2029 earnings per share estimates for Kura Oncology in a research report issued on Tuesday, November 10th. Brookline Capital Markets analyst L. Cann now anticipates that the comp

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

À lire aussi

Seeking Alpha

Victoria's Secret downgraded as turnaround story fully priced in—BofA Securities

 The Motley Fool

History Says the Nasdaq Will Soar Once Again in 2027 After the Sell-Off. The Best Growth Stock to Buy Before That Happens

 CNBC

Oil prices jump after Trump says no Iran deal needed: 'We've got their Strait'

 MarketWatch

It’s not ‘Medicare for All,’ but ‘Medicare for More.’ What this could mean for workers over 50.

 Investing.com

Turtlemint H1 FY27 slides: losses narrow 49% as revenue climbs 38%

 Benzinga

Best Energy Stocks